Objective: To report the case of a critically ill man with heparin-induced thrombocytopenia (HIT) who received a 125 mg overdose of the direct thrombin inhibitor argatroban. Case Summary: A ...

Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide (an ...

Findings seen among patients with acute ischemic stroke treated with intravenous thrombolysis within 3 hours after symptom onset. HealthDay News — Adjunctive treatment with intravenous argatroban or ...

Adding argatroban or eptifibatide does not improve outcomes for patients receiving IV thrombolysis for an acute ischemic stroke, the phase III MOST trial shows. Neither IV agent boosted 90-day ...

August 18, 2006 — Researchers report that initial safety data from the Argatroban tPA Stroke Study, a dose-escalation study of the combination of intravenous tissue plasminogen activator (tPA) and low ...

Review the side-effects of Argatroban as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Discover comprehensive details about Argatroban, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

PHOENIX -- Adjunctive thrombolysis with either argatroban or eptifibatide for acute ischemic stroke did not boost efficacy and contributed to risk, the MOST trial showed. When given after starting ...

Argatroban could revive the practice of acute anticoagulation for reducing disability after stroke, based on the EASE trial from China. In patients with acute ischemic stroke and early neurological ...

Teva announced the launch of Argatroban Injection in 0.9 percent Sodium Chloride. Teva announced the launch of Argatroban Injection in 0.9% Sodium Chloride. Argatroban is indicated for prophylaxis or ...

DUBLIN, April 17, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping argatroban injection to healthcare providers ...